TRV GP IV, LLC's Form 4 filing
Dianthus Therapeutics, Inc. (DNTH) · filed Feb 9, 2023
- Accession no.
- 0000899243-23-004411
- Filed
- Feb 9, 2023, 4:30 PM ET
- Trade date
- Feb 7-8, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.06M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| TRV GP IV, LLCCIK 0001688325 | 10% Owner |
| Third Rock Ventures GP IV, L.P.CIK 0001688326 | 10% Owner |
| Third Rock Ventures IV, L.P.CIK 0001688327 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2023 | Common Stock | SSaleDisposed | −2,200,000 | $0.83 | −$1,826,000 | 4,558,204 | Direct | |
| Feb 8, 2023 | Common Stock | SSaleDisposed | −1,500,000 | $0.82 | −$1,230,000 | 3,058,204 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.